CME Program Detail

Title: The 13th Annual Thoracic Symposium: Novel Treatments in Interventional Pulmonary and Robotic Thoracic Surgery
Date: Tue, Nov 7th, 2017
Time: 7:30 am - 12:15 pm
Location: Lang Auditorium

Statement of Need:
Benign and malignant pulmonary disease consists of many disorders that are common in our patient population today. There have been many recent advances in the diagnosis and treatment of these diseases. This 13th Annual NewYork-Presbyterian Queens Thoracic Symposium will review current trends, new technologies, and advances in the diagnosis and treatment of these disorders for primary care physicians and all others involved in the care of thoracic patients. Major topics that will be addressed include novel treatments for tracheobronchomalacia, novel bronchoscopic method for performing transbronchial lung biopsy, endobronchial lung volume reduction for COPD, navigational bronchoscopy and advanced robotic lung surgery. An evidence-based review of the role of medical and surgical therapy in the treatment of these disorders will be presented.This symposium will address the key and often controversial issues in the diagnosis and treatment of these disorders.

Target Audience:
Primary care physicians, hospitalists, pulmonologists, critical care physicians, thoracic surgeons, medical and radiation oncologists, pathologists, radiologists, nurses, physician assistants, and all
others involved in the care of patients with benign and malignant lung disorders.


Benjamin E. Lee, MD
Assistant Professor of Cardiothoracic Surgery, Weill Cornell Medical College
Chief, Thoracic Surgery, NewYork-Presbyterian Queens

Roger Maxfield, MD
Professor of Medicine, Columbia University Medical Center

Ryan Kern, MD
Assistant Professor of Medicine, Interventional Pulmonary Division of Pulmonary, Critical Care and Sleep Medicine
Mayo Clinic, Rochester, MN

George Cheng, MD, PhD
Interventional Pulmonary and Critical Care
Assistant Professor of Medicine, Duke University, Durham, NC

Eugene Shostak, MD
Assistant Professor of Medicine in Cardiothoracic Surgery; Interventional Pulmonologist
Weill Cornell Medical Center

Andrew Nguyen, MD
Assistant Professor of Cardiothoracic Surgery, Weill Cornell Medical Center
Disclosures: None


Benjamin Lee, MD, Andrew Nguyen, MD and Eugene Shostak, MD


• Identify new and innovative options in the treatment of COPD including endobronchial valve therapy for COPD.
• Recognize new technologies available in the treatment of airway stenosis including next generation 3-D printing for airway stenting.
• Identify and discuss the management of patients with tracheobronchomalacia including new treatment options such as robotic tracheobronchoplasty.
• Recognize advances in minimally invasive airway surgery including robotic sleeve resections
• Describe new advances in transbronchial biopsy


7:30-8:00 am
Registration / Continental Breakfast

8:00-8:05 am
Welcoming Remarks

8:05-8:10 am
Introduction to the Scientific Program
Benjamin E. Lee, MD

8:10-8:45 am
Bronchoscopic Lung Volume Reduction for Emphysema
Roger Maxfield, MD

8:45-8:55 am
Question and Answer Period

8:55-9:30 am
Transbronchial Cryobiopsy for Diffuse Parenchymal Lung Disease
Ryan Kern, MD

9:30-9:40 am
Question and Answer Period

9:40-10:15 am
Convergence of Medicine and Engineering–Personalization of Airway Prosthesis
George Cheng, MD, PhD

10:15-10:45 am
From Maximally to Minimally Invasive–Robotic Sleeve Resection
Benjamin E. Lee, MD

10:45-11:00 am
Question and Answer Period

11:00-11:30 am
Diagnosis and Evaluation of Tracheobronchomalacia–Whom to Treat?
Eugene Shostak, MD

11:30-12:00 pm
Robotic Tracheobronchoplasty
Andrew Nguyen, MD

12:00-12:15 pm
Question and Answer Period

12:15-1:15 pm

New York Hospital Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

New York Hospital Queens designates this Live Activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.

<< Back to Programs List

<< Back to Program Archive